Indian Pharma's Unwavering Allure: Why Mutual Funds Are Doubling Down Amidst Global Headwinds
Anil Rego's Urgent Market Warning: US-Exposed Pharma on Thin Ice Amidst Global Tariff Storm!
Indian Markets Reel: Nifty Registers Sharpest Weekly Decline in Seven Months, Pharma and IT Lead the Fall
Trump's Tariffs and Indian Pharma: A Looming Cloud of Uncertainty Over Specialty Drugs
Market Movers: The Stocks Poised for Dynamic Action on September 15th
Decoding the Paradox: Why Indian Pharma Stocks Are Plummeting Even After US Tariff Relief
Unlocking Potential: Why Glenmark Pharma is Poised for a Massive Upswing